Current evidence-based guidelines for the diagnosis and treatment of post-traumatic stress disorder (PTSD) are valuable resources and can be used to help develop individual treatment plans for patients. This on-demand… Read More
Otsuka Sr. MSL, Dr. Mark Tacelosky spoke with Dr. Brian Iacoviello who guided us through Cognitive Emotional Training for the treatment of major depressive disorder (MDD). Read More
Listen to Amica Simmons-Yon, PharmD, PhD and Aneta Fornal, PharmD as they spill the tea on Agitation in Alzheimer’s Dementia with special guest, Marc Agronin, MD. During this episode, Dr.… Read More
Dr. Chad Worz, Chief Executive Officer of the American Society of Consultant Pharmacists (ASCP) sits down with Justin Rash to discuss the ASCP organization and all that its members bring… Read More
Among respondents currently managing patients with AAD, 91% of respondents believed that there is stigma associated with AAD, 93% endorsed that stigma associated with AAD negatively impacts patient care, and… Read More
Care partners play an integral role in the detection and assessment of agitation symptoms in patients with Alzheimer’s dementia1 and are often the first to communicate these behaviors to healthcare providers… Read More
The Agitation in Alzheimer’s Screener for Caregivers (AASCTM) is a brief screening tool based on the International Psychogeriatric Association (IPA) consensus definition for agitation in cognitive disorders and was designed… Read More